At least a hundred protesters arrived at South Africa's parliament on 11 July to demonstrate their disapproval of the ongoing court case by Swiss pharmaceutical company Novartis against the Indian government over its patent laws. As the case draws to a close, health organizations say a win for the pharmaceutical company will be a loss to the developing world, which sources the bulk of its generic medicines from India. Novartis approached the Indian government six years ago, seeking to register a cancer drug already commonly marketed under the name Gleevec. The patent was denied and a long-running court battle ensued, but at each step Indian courts have ruled against Novartis and the company has appealed.

State hospitals and health clinics across Sierra Leone are facing severe shortages of drugs that should be supplied under the free healthcare programme because practitioners are diverting them for private sale, investigations by the Sierra Leone Anti-Corruption Commission (ACC) show. User fees for children under five and pregnant women were scrapped in 2010, allowing them to consult health practitioners and receive medication free of charge. One in 21 women in Sierra Leone dies from pregnancy or other causes, while over 17 per cent of children die before their fifth birthday, according to the UN Children’s Fund (UNICEF).

Child mortality rates have slowly come down, although they are still significantly high. Health experts say this is attributed to huge inequalities that exist in accessing health care. According to health experts at a Peoples’ Health Movement conference in Cape Town, last week, poverty and high unemployment rates are some of the barriers that prevent people from accessing quality health care. Director of the School of Public Health at the University of the Western Cape, Professor Dave Saunders, says child mortality in South Africa is still high and it has a direct link to the levels of unemployment and rising poverty.